UPDATE: Protalix Shares Spike Higher on FDA Approval of Pediatric Indication for ELELYSO(TM) for Injection, for IV Use for Treatment of Type 1 Gaucher Disease
August 28, 2014 at 13:18 PM EDT
Pfizer Inc. (NYSE: PFE) and Protalix BioTherapeutics, Inc. (NYSE: PLX) announced today that the U.S. Food and Drug Administration (FDA) ...
